NIO is the most admired EV brand in the world (fact) and will profitable before Tesla or Lucid produce a new platform, function or beat NIO in range

They will not engage in price war and therefore will produce a affordable and competitive car at a strong price point. 3.

PROFITING ALONG THE WHOLE PRODUCTION PROCESS AND LIFE OF THE AUTO.

$NIO Interesting to see they are building 2 new factories for their subrands

higher capacity battery bank.

NIO’S BUSINESS MODEL SUPPORTS IT AS NIO RAMPS PRODUCTION AND WORLDWIDE EXPANSION.✅✅

So if you project a full year production, G9 should be in the top 3 of that category if not 1st or 2nd.

Heads up, they have the capacity of becoming a major mobile phone player in China with a very high potential for world expansion.

Assuming December’s production level is sustained in the current quarter, deliveries could easily top 47,000 and produce growth near 85% versus last year.

and our production is going to double this year.

Industrial production rose by 2.4%, accelerating from December’s 1.3% growth.

It is literally the world’s factory.

China is producing Chips, at a large scale, they produce high quality chips and have no problems.

CN being world factory no shortage of pent up hungry consumers coming 3 years Covid lock out!

Global leader in the production of spherical graphite.

Major banks are bullish on Hong Kong’s economy and China growth prospects KEY POINTS 1) Major lenders Standard Chartered and HSBC expressed confidence in the rebound of Hong Kong’s and China’s economy, even as China ramps up its Covid measures.

Hang Seng tech now ramping up, +2.5%.

$BABA now ramping up, +7%.

$BABA +1.5% in US pre market as Nasdaq continues to ramp up, up close to 2% now..

The public hates animal testing BUT LOVES the medicines it produces.

In the year-over-year growth, the historical internal investments to increase capacity and expand our capabilities allowed us to experience organic growth of $20.9 million, up 91.3% from the growth achieved in the same period last year.

Also a good read-thru for $PSNL, who expanded capacity recently and launched a new site to match growing demand from biopharma.